Welcome to the ERACODA website
The European Renal Association COVID-19 Database is a European database collecting clinical information of patients on kidney replacement therapy with COVID-19.
Announcement 1 October 2020: Please note that cases diagnosed with COVID-19 in the autumn ("second wave" of the virus) can be registrered in ERACODA in the same manner as before.
The mission of ERACODA is to gain insight in what the COVID-19 epidemic means for patients treated with dialysis or a kidney transplantation across Europe, in the hope to improve their prognosis by intervening on modifiable risk factors.
The primary aim of ERACODA is to investigate the clinical course and outcomes (including hospital admission, intensive care admission and mortality) of patients on kidney replacement therapy with COVID-19. Such information may guide clinical treatment decisions and support triage strategies for admission to critical care units.
A secondary aim is to gain information on risk factors for mortality. Knowledge on modifiable patient and treatment characteristics associated with outcome may lead to interventions or changes in transplantation strategies that can improve prognosis.
What data are collected?
Data are collected from all outpatient and hospitalized adult patients (aged ≥18 years) with a functioning kidney allograft or on maintenance dialysis treatment who are diagnosed with COVID-19. This diagnosis needs to be based on a positive result on a real-time polymerase chain reaction (PCR) assay of nasal or pharyngeal swab specimens, and/or compatible findings on a CT scan or chest X-ray of the lungs.